Aesthetic Surgery Journal最新文献

{"title":"Local Tranexamic Acid in Facelift Surgery Is Not Associated With Wound Healing Complications: A Matched, Single-Surgeon Cohort Study.","authors":"Osama Darras, Pierce L Janssen, Elad Fraiman, Alvaro Reategui, James E Zins","doi":"10.1093/asj/sjaf130","DOIUrl":"https://doi.org/10.1093/asj/sjaf130","url":null,"abstract":"<p><strong>Background: </strong>Recent anecdotal reports from respected surgeons suggest a potential link between tranexamic acid (TXA) in local anesthetic solutions and wound healing complications during facelift procedures.</p><p><strong>Objectives: </strong>This study evaluates outcomes in patients undergoing facelift with and without local TXA injection.</p><p><strong>Methods: </strong>A single-surgeon retrospective cohort study was conducted on patients who underwent facelift surgery under general anesthesia between 2014 and 2024. All received subcutaneous injections of 0.5% lidocaine with 1:200,000 epinephrine, with or without TXA. Patients were matched for age, BMI, sex, and hypertension. Operative time and postoperative complications were assessed.</p><p><strong>Results: </strong>Each group had 261 patients with a median follow-up of 232 days. No significant differences were observed in age (p=0.22), BMI (p=0.59), sex (p=1.00), hypertension (p=0.52), primary vs. secondary facelifts (p=0.19), fat grafting (p=0.66), or chemical peels (p=0.83). Minor wound healing complications were similar (p=0.16). Delayed healing occurred in 4.6% (non-TXA) vs. 2.3% (TXA) (p=0.15). Minor skin necrosis was noted in one non-TXA patient (0.4%) and two TXA patients (0.8%) (p=1.00). Two major complications, major skin necrosis, were reported in the non-TXA group, none in TXA (p=0.5). Hematoma rates were comparable (p=1.00).</p><p><strong>Conclusions: </strong>This large-scale, single-surgeon, retrospective cohort study of matched patients study challenges previous claims associating TXA use with wound healing complications. Local administration of tranexamic acid (TXA) in a concentration of 1-2mg/mL is not associated with increased risk for minor or major wound healing complications in patients undergoing facelift procedures with wide skin undermining. TXA appears safe when used with appropriate dosing, screening, and technique.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Histomorphologic Outcomes of GalaFLEX Scaffold Used in Breast Surgery: Clinical Follow-up From 6 Weeks to 63 Months.","authors":"Bruce W Van Natta, Catalina Pineda Molina, Vincent Antonelli, George S Hussey, Stephen F Badylak","doi":"10.1093/asj/sjaf100","DOIUrl":"https://doi.org/10.1093/asj/sjaf100","url":null,"abstract":"<p><strong>Background: </strong>The use of scaffolds in reconstructive and aesthetic breast surgeries for soft tissue reinforcement has increased over time. However, histomorphologic outcomes with the use of such materials are not typically reported. The present study describes the histologic findings associated with the use of the GalaFLEX Scaffold by BD (Franklin Lakes, NJ), an absorbable biosynthetic material, when used as soft tissue support in breast surgery.</p><p><strong>Objectives: </strong>The present study evaluates the histomorphologic patterns of a 10-patient cohort that received GalaFLEX Scaffolds as soft tissue support in breast surgery, with and without breast implants.</p><p><strong>Methods: </strong>Tissue biopsy specimens that included the implanted GalaFLEX Scaffold were collected during revision from 6 weeks to 63 months postimplantation. General staining and specific immunolabeling were used to determine cellular infiltration, tissue composition and organization, and vascularization.</p><p><strong>Results: </strong>Biopsy specimens showed slow degradation of the GalaFLEX Scaffold, robust vascularization, mononuclear cell infiltration that decreased with time, and deposition of an organized collagenous connective tissue matrix in the interfiber space of the GalaFLEX Scaffold. There was no evidence for chronic inflammation or a foreign body response. The pattern of tissue remodeling around and within the fibers suggests a constructive tissue remodeling process rather than the formation of dense capsular tissue with contraction.</p><p><strong>Conclusions: </strong>Implantation of the GalaFLEX Scaffold for reconstructive and cosmetic breast surgery appears to be safe and is associated with slow scaffold degradation, neovascularization, and mononuclear cell infiltration that diminishes with time, and a constructive remodeling response devoid of chronic inflammation or foreign body response. These conclusions are limited by the size of the 10-patient cohort.</p><p><strong>Level of evidence: 4 (therapeutic): </strong></p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144564298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Application of Three-dimensional Measurement and Grayscale Value Measurement Techniques in Lower Eyelid Blepharoplasty.","authors":"Long Xiaohui, Lu Zhihao, Li Xiaojing, Zhang Huahui","doi":"10.1093/asj/sjaf133","DOIUrl":"https://doi.org/10.1093/asj/sjaf133","url":null,"abstract":"<p><strong>Background: </strong>Lower eyelid blepharoplasty addresses under-eye bags and tear troughs, but traditional evaluations lack objectivity. 3D imaging and grayscale analysis offer a novel, quantitative approach.</p><p><strong>Objectives: </strong>To objectively assess blepharoplasty outcomes using 3D imaging and grayscale analysis, validating their effectiveness in capturing morphological and skin texture changes.</p><p><strong>Methods: </strong>A self-controlled study of 68 patients (Jan-Jun 2023) used 3D imaging (EinScan H2) and grayscale analysis to measure pre- and postoperative changes. Key landmarks and grayscale values were analyzed using SPSS 22.0.</p><p><strong>Results: </strong>Postoperative 3D measurements showed reduced sagittal distance (P < 0.05) and increased grayscale values (P < 0.05), indicating improved morphology and skin texture. ICC values exceeded 0.80, confirming reproducibility.</p><p><strong>Conclusions: </strong>3D imaging and grayscale analysis provide objective, reliable evaluation of blepharoplasty outcomes, enhancing precision and paving the way for personalized treatment despite technical challenges.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nonhuman Primates Model of Super-selective Intraarterial Ophthalmic Arterial Interventional Thrombolysis for Treatment of Ophthalmic Arterial Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.","authors":"Xiao Xu, Youtao Yu, Xuer Sun, Ying Li, Hongdan Ding, Qiang Fu, Guiwen Zhou, Yi Ning, Bing Nie, Xinji Yang, Minliang Chen","doi":"10.1093/asj/sjaf132","DOIUrl":"https://doi.org/10.1093/asj/sjaf132","url":null,"abstract":"<p><strong>Background: </strong>Although intravascular interventional thrombolytic therapy is beneficial to patients suffering from impaired vision induced by hyaluronic acid (HA) embolism, there is no evidence-based medical evidence. In this study, we put forth a clinically relevant model of retinal ischemia and reperfusion in nonhuman primates and generate a retinal cell atlas of ischemia injury.</p><p><strong>Objectives: </strong>Evidence-based medicine proved that IATT can effectively improve the visual function of patients with visual impairment caused by facial injection of hyaluronic acid within a certain time window.</p><p><strong>Methods: </strong>Ophthalmic artery (OA) embolization in rhesus monkeys was induced by injecting hyaluronic acid(HA) into the ophthalmic artery, and reperfusion was achieved by intra-arterial thrombolysis therapy (IATT) with hyaluronidase immediately and at 1h, 4h, and 24h after embolization. Digital subtraction angiography (DSA) and fundus fluorescein angiography (FFA) were used to evaluate blood flow before and after retina reperfusion. Retinal structure and function before and after reperfusion were evaluated using electroretinography (ERG), hematoxylin and eosin (HE) staining, and transmission electron microscopy (TEM). scRNA-seq and bioinformatics analyses were used to detect retinal changes during different reperfusion window of opportunity.</p><p><strong>Results: </strong>DSA and FFA images confirmed ophthalmic arterial embolization completely after intra-arterial HA injection, and reperfusion after hyaluronidase-induced thrombolysis. ERG indicated retinal dysfunction following ischemia and recanalization exactly, and it was found that rcanalized the ophthalmic artery at 1 h, 4 h, or even 24 h could improve the visual function of the embolized eye, but immediately after recanalization to the 29th day after recanalization, the visual function of embolization time point in all three groups decreased to a certain extent. HE staining and TEM revealed ischemia-induced histological damage in the retina cells at different embolization time points. After single cell sequencing, it was found that the expression of RHO cytokines decreased with the extension of embolization time in reperfusion after 1 h,4h,6h of embolization.</p><p><strong>Conclusions: </strong>The rhesus monkey model of ophthalmic artery ischemia and reperfusion presented in this study closely simulated retina blood flow during ophthalmic artery ischemia and reperfusion in clinical practice and could help elucidate the molecular mechanisms underlying the visual impairment caused by retina tissue cells ischemia.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144551740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Efficacy and Safety of Injectable Tranexamic Acid Combination Therapies for Melasma: A Network Meta-analysis of Randomized Controlled Trials.","authors":"Houriah Y Nukaly, Khalid Alshareef, Ibrahim Abdullah S Albalawi, Waseem Alhawsawi, Zainab Ridha, Malika Ladha, Ruaa Alharithy, Abdulhadi Jfri","doi":"10.1093/asj/sjaf097","DOIUrl":"https://doi.org/10.1093/asj/sjaf097","url":null,"abstract":"<p><p>Melasma is a challenging hyperpigmentation disorder affecting predominantly women with darker skin tones. Despite various treatments, achieving consistent and effective results remains difficult. Tranexamic acid (TXA) has emerged as a promising therapeutic agent, particularly via intradermal injections, but its optimal concentration, delivery method, and combination therapies remain unclear. This study aims to evaluate the efficacy and safety of injectable TXA, focusing on its use alone and in combination with other treatments, such as hydroquinone, for melasma. A network meta-analysis of nine randomized controlled trials (RCTs) was conducted, involving 358 participants. Data on melasma subtype, TXA concentration, delivery method, and treatment outcomes (MASI scores) were extracted. Statistical analysis was performed using a random-effects model, assessing both direct and indirect comparisons. The combination of TXA and 4% hydroquinone showed the most significant improvement in MASI scores compared to other interventions, demonstrating superior efficacy. Adverse effects were mild and transient, including injection site pain and erythema, underscoring a favorable safety profile. Injectable TXA, especially in combination with hydroquinone, is an effective treatment for melasma. Standardized protocols and long-term studies are needed to optimize its use.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144537786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of the Degradability of Hyaluronic Acid by Ovine and Recombinant Human Hyaluronidase.","authors":"Tyler Safran, Roy Khalaf, Andrei Metelitsa, Julie Woodward, Andreas Nikolis","doi":"10.1093/asj/sjaf127","DOIUrl":"https://doi.org/10.1093/asj/sjaf127","url":null,"abstract":"<p><strong>Background: </strong>The mainstay of treatment in HA filler adverse events is the use of hyaluronidase; however, the dose and dilution are not standardized.</p><p><strong>Objectives: </strong>The objective of this study is to examine differential dilutions and concentrations of HYAL, as well as comparing the effectiveness of ovine to human HYAL.</p><p><strong>Methods: </strong>Fillers were selected for study based on a variety of rheologic factors. 0.2ml of product was selected for use based on prior studies. Degradation was assessed comparing both ovine and recombinant HYAL at differential concentrations and dilutions.</p><p><strong>Results: </strong>In the 2:1 group, by 50 minutes, Restylane Lidocaine degraded with 100U of ovine HYAL. No other complete degradation of fillers was noted. In terms of partial degradation, Restylane Lyft was noted to have partial degradation by 1 hour with 100U of HYAL. In both the 3:1 and 4:1 dilutions, RS and RL fillers were most susceptible to degradation, dissolving within 30 minutes with 100 units of recombinant HYAL and within 40 minutes with 100 units of ovine HYAL. Juvéderm and RHA fillers were the most resistant, requiring 300 units of HYAL for degradation within one hour. Beyond a 3:1 dilution ratio, no further improvement was observed.</p><p><strong>Conclusions: </strong>This study demonstrates that 300 units of hyaluronidase are sufficient to degrade 0.2mL of the most resistant HA fillers within one hour. Importantly, a minimum dilution of 3:1 should be used to provide adequate fluid for dissolving filler. Lastly, ovine HYAL may be just as effective as recombinant HYAL in terms of dissolving product.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The BREAST-Q Implant Surveillance Module (BREAST-Q IS) as a Predictor of Breast Implant Revision Surgery.","authors":"Michelle Merenda, Arul Earnest, Rasa Ruseckaite, Elisabeth Elder, Patrick Garduce, Susannah Ahern","doi":"10.1093/asj/sjaf128","DOIUrl":"https://doi.org/10.1093/asj/sjaf128","url":null,"abstract":"<p><strong>Background: </strong>The Australian Breast Device Registry (ABDR) records breast implant surgeries Australia-wide. In addition to clinical data, the ABDR has collected Patient Reported Outcome Measures (PROMs), to better understand patient outcomes following implant surgery.</p><p><strong>Objectives: </strong>Our objective was to assess the association between postoperative PROMs and revision surgery due to complications for reconstructive and cosmetic breast implant patients.</p><p><strong>Methods: </strong>A cohort study design was used. All primary breast augmentation and breast reconstruction implant insertion procedures with 2-years of follow-up after PROMs response, and with at least one PROM completed between 30th October 2017 and 16th May 2021 registered with the ABDR were identified. The primary outcome investigated was complications requiring revision at 2-years post PROMs completion. Binary logistic regression models were used to assess the predictive ability of PROMs.</p><p><strong>Results: </strong>5321 reconstructive procedures, and 25,777 cosmetic breast procedures were followed. Multivariate regression for the reconstructive cohort showed 3 PROM variables, feel, rippling and tightness, predicted revision due to complications within 2-years of PROMs response, OR 0.71, 95% CI 0.56-0.90; p equals 0.004, OR 0.70, 95% CI 0.57-0.87; p less than 0.001, and OR 0.80, 95% CI 0.69-0.93; p equals 0.003 respectively. Multivariate regression for the cosmetic cohort showed 3 PROM variables, look, rippling and tightness, predicted revision due to complications within 2-years of PROMs response, OR 0.51, CI 0.42-0.63; p less than 0.001, OR 0.78, CI 0.63-0.95; p equals 0.014, and OR 0.79, CI 0.67-0.94; p equals 0.006 respectively.</p><p><strong>Conclusions: </strong>Postoperative PROMs were significantly associated with revision surgery due to complications. PROMs may be used to predict the likelihood of complications and revision following breast implant surgery.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinically Relevant One-shot Learning Technique to Personalize Fractional CO2 Laser Treatment for Eyelid Scars.","authors":"Dingqiao Wang, Zhen Mao, Wuyou Gao, Yanjing Huang, Xingyi Li, Jun Mao, Rongxin Chen, Xuanwei Liang, Xianchai Lin","doi":"10.1093/asj/sjaf091","DOIUrl":"https://doi.org/10.1093/asj/sjaf091","url":null,"abstract":"<p><strong>Background: </strong>Hypertrophic and keloid eyelid scars cause functional and aesthetic problems. Traditional fractional CO₂ laser treatments require multiple sessions and use uniform parameters regardless of scar characteristics, limiting their effectiveness for complex eyelid scars.</p><p><strong>Objectives: </strong>To evaluate the efficacy and safety of the Manual One-shot Learning Technique (MOST) with fractional CO₂ laser for personalized treatment of eyelid scars.</p><p><strong>Methods: </strong>A retrospective study involved 154 patients with hypertrophic and keloid eyelid scars treated with the MOST fractional CO₂ laser. Functional and aesthetic outcomes were assessed using degree of incomplete eyelid closure, ectropion and Vancouver Scar Scale (VSS). Patients were followed up for a total of 12 months to evaluate outcomes and monitor complications.</p><p><strong>Results: </strong>The study included 154 patients (98 males, 56 females; mean age 32.6±14.2 years). A single treatment session resulted in significant improvements, with a mean VSS score reduction of 2.75 ± 1.50 (P = 0.021), and 57.8% of patients achieving > 75% scar clearance. After 1-3 treatment sessions, all patients showed significant functional and aesthetic improvements, with incomplete eyelid closure and ectropion significantly reduced (both P < 0.001), VSS scores decreased by 3.02 ± 1.76 (P < 0.001), and 90.9% of patients achieved > 75% scar clearance. Complications included recurrence (10.4%), hypopigmentation (5.2%), and skin atrophy (5.2%).</p><p><strong>Conclusions: </strong>The MOST laser technique significantly improves functional and aesthetic outcomes for eyelid scars with fewer treatment sessions. By personalizing treatment based on tissue response, this approach enhances efficiency while reducing both patient burden and resource use.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endoscopic Deep Plane Facelift: A Classified Approach.","authors":"Mirza Firat","doi":"10.1093/asj/sjaf110","DOIUrl":"https://doi.org/10.1093/asj/sjaf110","url":null,"abstract":"<p><strong>Background: </strong>Traditional facelift techniques, although effective in addressing facial aging, are often associated with visible scarring and stigmas. These factors contribute to patient hesitation and a growing preference for non- surgical alternatives. In recent years, endoscopic approaches have gained popularity by offering scar-concealed access and deep plane dissection, but many techniques lack a standardized framework for patient selection and reproducibility.</p><p><strong>Objectives: </strong>The objective of this study is to present a systematic endoscopic facelift technique which proposes a five-group classification system to guide patient-specific surgical planning and optimize aesthetic outcomes.</p><p><strong>Methods: </strong>A total of 393 patients underwent endoscopic facelift surgery performed by a single surgeon between 2020 and 2024. Patients were categorized into five groups based on facial aging patterns and anatomical needs, including browlift, midface lift, lower facelift, and neck correction. The technique emphasized minimal skin undermining, vertical vector elevation, and cable suture suspension. All patients were followed for a minimum of 12 months postoperatively. Complications, revisions, and outcomes were recorded prospectively.</p><p><strong>Results: </strong>There were no cases of permanent nerve injury. Revision surgery for cosmetic concerns was performed in 19 patients (4.8%), most of whom were among the first 100 cases.</p><p><strong>Conclusions: </strong>This vertical vector endoscopic facelift technique demonstrates consistent aesthetic results with a low complication and revision rate. By combining a classification-based surgical strategy with minimally invasive access and deep anatomical correction, this method offers a reproducible, safe, and natural-appearing alternative to traditional facelift approaches. Future studies will aim to incorporate objective assessments and patient- reported outcome measures.</p>","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Commentary on: The Medicolegal Challenges of Facial Plastic Surgery: A Systematic Review.","authors":"Christopher L Nuland","doi":"10.1093/asj/sjaf124","DOIUrl":"https://doi.org/10.1093/asj/sjaf124","url":null,"abstract":"","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}